Carregant...

Antihypertensive Pharmacogenetic Effect of Fibrinogen-beta Variant -455 G>A on Cardiovascular Disease, End-Stage Renal Disease and Mortality: The GenHAT Study

OBJECTIVE: The FGB gene codes for fibrinogen-beta, a polypeptide of the coagulation factor fibrinogen, which is positively associated with cardiovascular diseases. Studies show ACE inhibitors lower plasma fibrinogen concentrations, whereas diuretics and calcium channel blockers do not. Since carrier...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Lynch, Amy I., Boerwinkle, Eric, Davis, Barry R., Ford, Charles E., Eckfeldt, John H., Leiendecker-Foster, Catherine, Arnett, Donna K.
Format: Artigo
Idioma:Inglês
Publicat: 2009
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2764310/
https://ncbi.nlm.nih.gov/pubmed/19352213
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FPC.0b013e32832a8e81
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!